Searchable abstracts of presentations at key conferences in endocrinology

ea0091cb13 | Additional Cases | SFEEU2023

Persistent Hyperthyroidism Secondary to Ectopic Autonomous Thyroid Tissue

Subbiah Kasi , Khalilova Samira , Sathyanarayan Sheela , Dimitriadis Georgios

A 28 year old lady presented with a 4 month history of anxiety, palpitations, weight loss and a pressure sensation in the neck. On examination she had fine tremor of her outstretched fingers and no palpable goitre with a regular heart rate. FT4 was 22 pmol/l(10.3-24.5), FT3 7.9 pmol/l(3.5-6.5), TSH 0.02 mIU/l(0.3-5.5), TSH receptor antibodies (TRAb) <0.9 U/l(0-1.75) and TPO antibodies <4 IU/ml (0-35). She was started on Carbimazole 20 mg daily and after being well cont...

ea0048o7 | Oral Communications | SFEEU2017

Hypertestosteronemia and primary infertility due to an extragonadal germ cell tumor of the anterior mediastinum

Dimitriadis Georgios K , Kaltsas Gregory , Randeva Harpal S

A 26-year-old Caucasian male presented to the joint infertility outpatients clinic with primary infertility. His medical history included hypertrophic cardiomyopathy (HCM) due to genetically confirmed MYH7 sarcomere protein mutation, treated with implantable cardioverter-defibrillator while his partner was a healthy 24-year-old Caucasian nulliparous female. Initial investigations showed hypertestosteronemia (Testosterone: >51.0 nmol/l) and azoospermia, hence the c...

ea0074ncc13 | Highlighted Cases | SFENCC2021

Refractory Graves’ disease following total thyroidectomy caused by concurrent ectopic thyroid tissue in the anterior mediastinum

Sathyanarayan Sheela , Li Adrian , Arshad Sobia , Dimitriadis Georgios K

Case History :A 34-year-old Caucasian female patient presented in May 2015 to A&E with symptoms of overt thyroid dysfunction. She was managed medically until June 2016 when thionamide treatment was withdrawn. Unfortunately, this lady had a first disease relapse in July 2018 whilst she was pregnant at 35 weeks of gestation and then further disease relapse in January 2020 during her second pregnancy. Investigations: Initial biochemistry in 2015 confirm...

ea0074ncc14 | Highlighted Cases | SFENCC2021

Multiple electrolyte disturbances as the presenting feature of MEN-1

Li Adrian , Sathyanarayan Sheela , Arshad Sobia , Aylwin Simon , Dimitriadis Georgios

Case history: A 49-year-old teacher presented to his GP with lethargy and lower limb weakness. He had noticed polydipsia and polyuria, and had experienced weight loss albeit with an increase in central abdominal fat mass. He had previously undergone cholecystectomy and colonic polypectomy. He took no regular medications. Investigations: He had hypercalcaemia 3.34 mmol/l with PTH of 356 ng/l and hypokalaemia 2.7 mmol/l and was admitted for intravenous flu...

ea0094p92 | Neuroendocrinology and Pituitary | SFEBES2023

A functioning gonadotroph macroadenoma presenting with features of OHSS and sustained remission 4-years after TSS

Khalilova Samira , Gonzales Christine , E Drakou Eftychia , K Dimitriadis Georgios

It is well established that the majority of the immunohistochemically confirmed gonadotroph adenomas are hormonally silent, accounting almost 64% of all clinically nonfunctioning pituitary adenomas. Whereas clinically functioning gonadotroph adenomas (FGA) are very rare and the exact prevalence is not known. We present the case of a FGA in a premenopausal. A 31-year-old female presented in the ED with oligomenorrhea for 11 months, abdominal pain and distention over the precedi...

ea0094p239 | Neuroendocrinology and Pituitary | SFEBES2023

An aggressive prolactinoma with orbital involvement and excellent response to treatment with temozolamide. A case report and systematic literature review

Khalilova Samira , Gonzales Christine , E Drakou Eftychia , K Dimitriadis Georgios

A proportion of prolactinomas exhibit aggressive features (including invasiveness, relevant growth despite adequate dopamine agonist treatment, and recurrence potential) and few may exhibit metastasizing potential (carcinomas). We present an uncommon case of intra-orbital spread from a large infiltrative prolactinoma, with excellent response to temozolomide and a systematic review of the literature. A 55y.o male patient presented with generalized weakness and hyponatraemia. Fu...

ea0050p336 | Obesity and Metabolism | SFEBES2017

Metabolic phenotype of Male Obesity-associated Secondary Hypogonadism pre- and post-replacement therapy with intra-muscular Testosterone undecanoate therapy

Dimitriadis Georgios K , Randeva Harpal S , Grammatopoulos Dimitris K , Barber Thomas M

Aim: To explore the metabolic phenotype of Male Obesity-associated Secondary Hypogonadism (MOSH) and following treatment with long-acting intramuscular (IM) testosterone undecanoate.Methods: A prospective observational pilot study on metabolic effects of IM testosterone undecanoate in MOSH (Hypogonadal [HG] group, n=13), including baseline comparisons with controls (Eugonadal [EG] group, n=15). Half the subj...

ea0050p336 | Obesity and Metabolism | SFEBES2017

Metabolic phenotype of Male Obesity-associated Secondary Hypogonadism pre- and post-replacement therapy with intra-muscular Testosterone undecanoate therapy

Dimitriadis Georgios K , Randeva Harpal S , Grammatopoulos Dimitris K , Barber Thomas M

Aim: To explore the metabolic phenotype of Male Obesity-associated Secondary Hypogonadism (MOSH) and following treatment with long-acting intramuscular (IM) testosterone undecanoate.Methods: A prospective observational pilot study on metabolic effects of IM testosterone undecanoate in MOSH (Hypogonadal [HG] group, n=13), including baseline comparisons with controls (Eugonadal [EG] group, n=15). Half the subj...

ea0086p330 | Metabolism, Obesity and Diabetes | SFEBES2022

Glicentin concentrations following Liraglutide treatment in patients with overweight/obesity

Al-Hasani Wiaam , Ranasinghe Ruvini , Luxton James , Mare Tracey , Dimitriadis Georgios K , Vincent Royce P

Background: Liraglutide is a long-acting glucagon-like peptide-1(GLP-1) receptor agonist that promotes weight loss. The minimum adequate/good response to liraglutide (≥5% weight loss at 3 months) is not achievable in all patients. Currently there are no biomarkers to predict good response. Enhanced postprandial glicentin concentration was recently considered as superior to GLP-1 in predicting weight loss following bariatric surgeries.Objective 1) T...

ea0091p18 | Poster Presentations | SFEEU2023

Recurrent symptomatic pituitary hyperplasia mimicking macroprolactinoma in pregnancy

Onyema Michael , Tanveer Quratulain , Khalilova Samira , Lajeunesse-Trempe Fannie , Aylwin Simon , Dimitriadis Georgios K.

(1) 30-year-old woman presenting at 34 weeks of pregnancy with symptoms of persisting headaches, diplopia and nausea. She presented again 4 years later with similar symptoms in a subsequent pregnancy at 35 weeks with additional complaints of blurred peripheral vision. (2) During her first pregnancy biochemistry revealed marked prolactin elevation (14,000 mIU/l). A non-contrast MRI scan of the pituitary revealed significant enlargement of the gland (22 x 14.4 x 12.5mm) bey...